Skip to main content
  1. Right Decisions
  2. Maternity & Gynaecology Guidelines
  3. Maternity
  4. Back
  5. Antenatal, general
  6. Antenatal Fetal HR Monitoring Outpatient (675)
Important: please update your RDS app to version 4.7.3

Welcome to the March 2025 update from the RDS team

1.     RDS issues - resolutions

1.1 Stability issues - Tactuum implemented a fix on 24th March which we believe has finally addressed the stability issues experienced over recent weeks.  The issue seems to have been related to the new “Tool export” function making repeated calls for content when new toolkit nodes were opened in Umbraco. No outages have been reported since then, and no performance issues in the logs, so fingers crossed this is now resolved.

1.2 Toolkit URL redirects failing– these were restored manually for the antimicrobial calculators on the 13th March when the issue occurred, and by 15th March for the remainder. The root cause was traced to adding a new hostname for an app migrated from another health board and made live that day. This led to the content management system automatically creating internal duplicate redirects, reaching the maximum number of permitted redirects and most redirects therefore ceasing to function.

This issue should not happen again because:

  • All old apps are now fully migrated to RDS. The large number of migrations has contributed to the high number of automated redirects.
  • If there is any need to change hostnames in future, Tactuum will immediately check for duplicates.

1.3 Gentamicin calculators – Incidents have been reported incidents of people accessing the wrong gentamicin calculator for their health board.  This occurs when clinicians are searching for the gentamicin calculator via an online search engine - e.g. Google - rather than via the health board directed policy route. When accessed via an external search engine, the calculator results are not listed by health board, and the start page for the calculator does not make it clearly visible which health board calculator has been selected.

The Scottish Antimicrobial Prescribing Group has asked health boards to provide targeted communication and education to ensure that clinicians know how to access their health board antimicrobial calculators via the RDS, local Intranet or other local policy route. In terms of RDS amendments, it is not currently possible to change the internet search output, so the following changes are now in progress:

  • The health board name will now be displayed within the calculator and it will be made clear which boards are using the ‘Hartford’ (7mg/kg) higher dose calculator
  • Warning text will be added to the calculator to advise that more than one calculator is in use in NHS Scotland and that clinicians should ensure they access the correct one for their health board. A link to the Right Decision Service list of health board antimicrobial prescribing toolkits will be included with the warning text. Users can then access the correct calculator for their Board via the appropriate toolkit.

We would encourage all editors and users to use the Help and Support standard operating procedure and the Editors’ Teams channel to highlight issues, even if you think they may be temporary or already noted. This helps the RDS team to get a full picture of concerns and issues across the service.

 

2.     New RDS presentation – RDS supporting the patient journey

A new presentation illustrating how RDS supports all partners in the patient journey – multiple disciplines across secondary, primary, community and social care settings – as well as patients and carers through self-management and shared decision-making tools – is now available. You will find it in the Promotion and presentation resources for editors section of the Learning and support toolkit.

3.     User guides

A new user guide is now available in the Guidance and tips section of Resources for providers within the Learning and Support area, explaining how to embed content from Google Calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream and Jotforms into RDS pages. A webinar for editors on using this new functionality is scheduled for 1 May 3-4 pm (booking information below.)

A new checklist to support editors in making all the checks required before making a new toolkit live is now available at the foot of the “Request a new toolkit” standard operating procedure. Completing this checklist is not a mandatory part of the governance process, but we would encourage you to use it to make sure all the critical issues are covered at point of launch – including organisational tags, use of Alias URLs and editorial information.

4.Training sessions for RDS editors

Introductory webinars for RDS editors will take place on:

  • Tuesday 29th April 4-5 pm
  • Thursday 1st May 4-5 pm

Special webinar for RDS editors – 1 May 3-4 pm

This webinar will cover:

  1. a) Use of the new left hand navigation option for RDS toolkits.
  2. b) Integration into RDS pages of content from external sources, including Google Calendar, Google Maps and simple Jotforms calculators.

Running usage statistics reports using Google analytics

  • Wednesday 23rd April 2pm-3pm
  • Thursday 22nd May 2pm-3pm

To book a place on any of these webinars, please contact Olivia.graham@nhs.scot providing your name, role, organisation, title and date of the webinar you wish to attend.

5.New RDS toolkits

The following toolkits were launched during March 2025:

SIGN guideline - Prevention and remission of type 2 diabetes

Valproate – easy read version for people with learning disabilities (Scottish Government Medicines Division)

Obstetrics and gynaecology induction toolkit (NHS Lothian) – password-protected, in pilot stage.

Oral care for care home and care at home services (Public Health Scotland)

Postural care in care homes (NHS Lothian)

Quit Your Way Pregnancy Service (NHS GGC)

 

6.New RDS developments

Release of the redesign of RDS search and browse, archiving and version control functionality, and editing capability for shared content, is now provisionally scheduled for early June.

The Scottish Government Realistic Medicine Policy team is leading development of a national approach to implementation of Patient-Reported Outcome Measures (PROMs) as a key objective within the Value Based Health and Care Action Plan. The Right Decision Service has been commissioned to deliver an initial version of a platform for issuing PROMs questionnaires to patients, making the PROMs reports available from patient record systems, and providing an analytics dashboard to compare outcomes across services.  This work is now underway and we will keep you updated on progress.

The RDS team has supported Scottish Government Effective Prescribing and Therapeutics Division, in partnership with Northern Ireland and Republic of Ireland, in a successful bid for EU funding to test develop, implement and assess new integrated care pathways for polypharmacy, including pharmacogenomics. As part of this project, the RDS will be working with NHS Tayside to test extending the current polypharmacy RDS decision support in the Vision primary care electronic health record system to include pharmacogenomics decision support.

7. Implementation projects

We have just completed a series of three workshops consulting on proposed improvements to the Being a partner in my care: Realistic Medicine together app, following piloting on 10 sites in late 2024. This app has been commissioned by Scottish Government Realistic Medicine to support patients and citizens to become active partners in shared decision-making and encouraging personalised care based on outcomes that matter to the person. We are keen to gather more feedback on this app. Please forward any feedback to ann.wales3@nhs.scot

 

 

Antenatal Fetal HR Monitoring Outpatient (675)

Warning Warning: This guideline is 372 day(s) past its review date.
Please report any inaccuracies or issues with this guideline using our online form

There is a recognised need for fetal monitoring for high risk patients. Although there is no clear evidence that antenatal cardiotocography improves perinatal outcome (Grivell et al, 2015) the main purpose of CTG recordings is to identify when there is concern about fetal well-being to enable interventions to be carried out before the fetus is harmed (Beckmann 2014).

The aim of this guideline is to provide a standardised approach to CTG interpretation within the antenatal setting in high risk patients.

Antepartum cardiotocography (CTG) should be considered in women of 26+0 gestation and above. CTG’s carried out before 28 weeks should be performed and interpreted with caution, the decision to do so must be made on an individual basis by a senior obstetrician. The fetal autonomic nervous system is not mature and therefore the patterns of fetal heart rate which may be expected at later gestations are not present. Also there is increased possibility of signal loss and poor quality CTG at earlier gestations (Afors and Chandraharan, 2011). All CTG traces should be peer reviewed by a trained team member. However, all normal CTG traces on fetuses below 32 weeks gestation should also be peer reviewed by an obstetrician (≥ST2) prior to discharging the woman home.

If CTG is of poor quality there should be early recourse to ultrasound location of the fetal heart rate (ideally within 20 minutes).

 

Abdominal examination

A full abdominal examination should be carried out and documented prior to commencing a CTG trace. Ensure the woman has emptied her bladder and is comfortable. Measure fundal height in centimetres, palpate and document the findings. The fetal heart should be auscultated with a Pinard or doptone prior to commencement (Perinatal Institute 2018).

Documentation/ Labelling CTG

All CTG traces  should be labeled with the woman’s name and CHI , the date and time the CTG was commenced , The fetal heart rate on doptone prior to commencing the ctg and the maternal pulse.

Cardiotocography interpretation

When reviewing the cardiotocograph (CTG) trace it is important to assess and document any contractions and all four features of fetal heart rate;

  • Baseline rate
  • Baseline variability
  • Presence or absence of decelerations
  • Presence of accelerations

It is also important to record maternal heart rate. Where there is any difficulty in categorising or interpreting a CTG trace, a review by a senior midwife or obstetrician should be obtained.

The RCOG Green-top Guideline on the management of reduced fetal movements recommends that interpretation of the antenatal CTG fetal heart rate pattern can be assisted by adopting the NICE classification of fetal heart rate features as indicated in their intrapartum care guideline. Therefore, as is the case when classifying intrapartum CTGs, it would seem reasonable to use a structured pro forma to ensure the use of consistent terminology. However, using an intrapartum pro forma is not appropriate as it acknowledges that some decelerations are acceptable in labour, which clearly cannot be the case for antenatal CTGs where there are no contractions.

 

Baseline rate (beats/minute) This is the average fetal heart rate within a ten minute window.

Baseline variability (beats/minute) This refers to the variation of fetal heart rate from one beat to the next. Variability occurs as a result of the interaction between the nervous system, chemoreceptors, baroreceptors and cardiac responsiveness.

 Accelerations are an abrupt increase in the baseline fetal heart rate of greater than 15 bpm for greater than 15 seconds. The presence of fetal heart rate accelerations, even with reduced baseline variability, is generally a sign that the baby is healthy.

Decelerations are an abrupt decrease in the baseline fetal heart rate of greater than 15 bpm for greater than 15 seconds.

Any decelerations on an antenatal CTG should be considered abnormal and prompt medical review.

This pro forma has been adapted from PROMPT training and should be utilised for the classification of CTG traces in non-labouring women only.

Antenatal CTG

Reassuring

Non-reassuring

Baseline rate (bpm)

110-160 Rate:

Less than 109

More than 161

Sinusoidal pattern for 10mins or more

Variability (bpm)

5 bpm or more

Less than 5 bpm for more than 40 minutes

Acceleration

Present

None for 40 minutes

Decelerations

None

Unprovoked deceleration/s

Decelerations related to uterine tightening (not in labour)

Opinion

Normal CTG

(all features reassuring)

Abnormal CTG                       (1 or

more non-reassuring features)

 

Antenatal CTG classification

Normal:       A CTG where all four features fall into the ‘reassuring’ category.

Abnormal: A CTG with any non reassuring features (including any decelerations).

When an abnormal CTG is identified, it should be reviewed by an experienced obstetrician as soon as possible (within 30 minutes) to make a clear individualised action plan

 

Conservative measures

If there are any concerns about the baby’s wellbeing, be aware of the possible underlying causes and start one or more of the following conservative measures based on assessment of the most likely causes: encourage the woman to mobilise or adopt an alternative position ( and to avoid being supine); offer intravenous fluids if the woman is hypotensive or tachycardic.

All cardiotocograph traces must be peer reviewed prior to completion by either a member of midwifery staff or an obstetrician and documented appropriately. If conservative measures fail to resolve an abnormal CTG trace, immediate review by an obstetrician should be sought and a clear and concise plan documented.

 

Preterm Fetal Monitoring

Antepartum cardiotocography should be considered in women of 26+0 weeks gestation and above. Any CTG carried out before 26 weeks should be performed and interpreted with caution. The decision to do so must be based on an individual basis by a consultant obstetrician.

Evidence suggests that the baseline fetal heart rate in preterm fetuses is at the higher end of the normal range for a term fetus for physiological reasons, but that this reverts to the range more consistent with term fetuses as gestation advances. However, any rate more than 160 bpm should be defined as tachycardia across all preterm gestational ages. The baseline variability may be reduced at preterm gestations for physiological reasons. However, at term, fetal heart rate variability is an important clinical indicator of fetal acid base balance and oxygenation of the autonomic nerve centres within the brain (NICE 2015).

Fetal heart rate decelerations are common and normal at very early preterm gestations (26 weeks and less) reflecting immature development of cardioregulatory mechanisms. The presence of shallow or short-lived decelerations in very preterm babies should not be considered necessarily as indicative of hypoxia when all other CTG features are reassuring.

From 32 weeks, baseline fetal heart rate and variability should be similar to that in term fetuses and accelerations with an amplitude of more than 15 beats from the baseline should be present as an indicator of fetal wellbeing. Decelerations can be interpreted as for the term fetus (NICE, 2015).

Editorial Information

Last reviewed: 11/04/2019

Next review date: 01/04/2024

Author(s): Julie Murphy.

Approved By: Obstetrics Clinical Governance Group

Document Id: 675

References

Afors, K. and Chandraharan, E. (2011) Use of Continuous Electronic Fetal Monitoring in a Preterm Fetus: Clinical Dilemmas and Recommendations for Practice. Journal of Pregnancy Volume 2011, Article ID 848794. Available at https://www.hindawi.com/journals/jp/2011/848794/

Beckmann, M. (2014) National German Guideline: Guideline on the use of CTG During Pregnancy and Labour. Geburtsh Frauenheilk.

Grivell RM, Alfirevic Z, Gyte GML, Devane D. Antenatal cardiotocography for fetal assessment (2015). Cochrane Database of Systematic Reviews, Issue 9. Art. No.: CD007863. DOI: 10.1002/14651858.CD007863.pub4.

Kopecky, E, Ryan, M, Barrett et al (2000) Fetal response to maternally administered morphine. American Journal of Obstetrics and Gynaecology. Vol 183-2, August Available at https://ac.els-cdn.com/S0002937800746710/1-s2.0S0002937800746710- main.pdf?_tid=77089bd4-3733-4276-9b11- f5216d79c2f0&acdnat=1521122523_2af4473790c63d9f12e65e3d59fd5cbe

National Institute for Health Care and Excellence (2017) Intrapartum Care (NICE Guideline CG190) Available at: https://www.nice.org.uk/guidance/cg190

National Institute for Health Care and Excellence (2015) Preterm Labour and Birth (NICE Guideline 25) Available at:https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0080792/pdf/PubMedHealth_PM H00

80792.pdf

Perinatal Institute (2018) Fetal Growth- Fundal Height Measurements. Available online at:

https://www.perinatal.org.uk/FetalGrowth/FundalHeight.aspx